Istitut Català d'Oncologia, Hospital Duran i Reynals

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients	splenic marginal zone lymphoma	Active, not recruiting	Phase 3	2026-07-22		NCT05735834

Clinical trials